SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Genpharmasec informs about updates on acquisition

11 Mar 2024 Evaluate
Genpharmasec has informed that in continuation to intimation dated 19th September, 2023, wherein Genpharmasec (the Company) had made disclosures under Reg. 30 of the listing regulations, 2015 informing the execution of Share Purchase Agreement [SPA] and Share Subscription cum Shareholders Agreement [SSSA] in relation to acquire of 70% stake in Derren Healthcare in a staged manner, the Company has as on 11 March, 2024 acquired the 70% stake in Derren Healthcare. They are enclosing the information pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 read with SEBI Circular number CIR/CFD/CMD/4/2015 dated 9th September, 2015 as Annexure-A.

The above information is a part of company’s filings submitted to BSE. 

Genpharmasec Share Price

1.17 0.04 (3.54%)
20-Apr-2026 14:33 View Price Chart
Peers
Company Name CMP
Redington 227.95
Adani Enterprises 2249.10
Amrapali Industries 17.99
Rashi Peripheral 474.85
PDS 293.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×